Clopidogrel-induced hepatotoxicity [2];Hepatotoxicidad por clopidogrel

Medicina Clinica

Volumn 120, Issue 4, 2003, Pages 156-157

  Ramos Ramos, Juan Carlos ^a   Moreno, José Sanz ^a   Calvo Carrasco, Laura ^a   de Dios García Díaz, Juan ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM ANTAGONIST; CLOPIDOGREL; OMEPRAZOLE; RANITIDINE;

AGED; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CYTOLOGY; DISEASE COURSE; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; DUODENUM BLEEDING; ECHOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; HYPERTENSION; LETTER; LIVER BIOPSY; LIVER DISEASE; PARACENTESIS; PERITONEAL DISEASE; SEROLOGY;

EID: 0037425995     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042995     Document Type: Letter

References (10)

1. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999;100:1667-72.
2. The CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischemic events (CAPRIE). Lancet 1996;348:1329-39.
3. Carvajal García-Pando A, García Ortega P, Rueda de Castro AM, García del Pozo J. Ticlopidina y reacciones adversas hepáticas. Datos recogidos por el Sistema Español de Farmacovigilancia. Med Clin (Barc) 1999;112:557-8.
4. Iqbal M, Goenka P, Young MF, Thomas E, Borthwick TR. Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature. Dig Dis Sci 1998;43:2223-6.
5. De la Iglesia Martínez F, Trinidad San José JC, Nicolás Miguel R, Ramos Polledo V, Pellicer Vázquez C, Diz-Lois Martínez F. Hepatitis colestásica por ticlopidina. An Med Interna 2000;17: 504-5.
6. García Ortega P, José Navarro J, Carvajal A, García del Pozo J. Hepatitis colestásica por ticlopidina. Med Clin (Barc) 2001;116:117.
7. Blanco JR, Márquez M, Salcedo J, Zabala M. Hepatopatía precoz inducida por ticlopidina. An Med Interna 2001;18:48-9.
8. Tsui PT, Lai ST, Leung WS, Mok NS, Wu CW, Lau ST, et al. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy. Hong Kong Med J 2002;8:57-9.
9. Zeolla MM, Carson JJ. Successful use of clopidogrel for cerebrovascular accident in a patient with supected ticlopidine-induced hepatotoxicity. Ann Pharmacother 1999;33:939-41.
10. Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000;7:317-8.